JAMP Pantoprazole Sodium 40mg: Affected lots may contain oversized or undersized tablets
Brand(s)
Last updated
Summary
Product
JAMP Pantoprazole Sodium 40mg
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
JAMP |
JAMP Pantoprazole Sodium 40mg |
DIN 02392623 |
Tablet |
PANTOPRAZOLE (PANTOPRAZOLE SODIUM SESQUIHYDRATE) 40 MG |
EG23PAM004, EG24PAM002, EG24PAM003 Additional Lots added: |
Issue
Affected lots may contain oversized or undersized tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation.
1310 Nobel,
Boucherville, QC,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75945
Get notified
Receive notifications for new and updated recalls and alerts by category.